Cabotegravir and Rilpivirine Extended-Release Injectable Suspensions (Cabenuva(R))

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025